PRERETRO: Validation of the French Translation of a Self-questionnaire Looking for a History of Pre-eclampsia.

Sponsor
University Hospital, Brest (Other)
Overall Status
Recruiting
CT.gov ID
NCT04658966
Collaborator
(none)
500
1
12
41.7

Study Details

Study Description

Brief Summary

PRERETRO is a study for validation of the French translation of a self-questionnaire looking for a history of pre-eclampsia of more than 5 years in women who have already had a pregnancy of more than 6 months with childbirth at Brest University Hospital.

Condition or Disease Intervention/Treatment Phase
  • Other: administration of a self-questionnaire

Detailed Description

This study will help to evaluate the specificity and sensitivity of the French translation of a self-questionnaire looking for a history of pre-eclampsia in women who gave birth at Brest University Hospital before year 2015.

First, women with pre-eclampsia (cases) and women with no hypertensive disorders (controls) during pregnancy were identified with the Medical Registry Database (MRD) of Brest University maternity ward.

All pre-eclampsia diagnoses were reviewed by 2 experts in order to confirm the accuracy of the diagnosis.

250 cases and 250 controls were finally selected after consultation of their medical file and were pre-included in the study.

Then, the 500 women will be contacted by phone or e-mail in order to inform them about the study and to offer them the possibility to participate in the study.

The women who will agree to participate in the study will fill in an online self-questionnaire on pre-eclampsia.

Their responses will then be compared to the diagnosis retained after consultation of their medical file.

Sensitivity and specificity of the questionnaire will then be evaluated.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Validation of the French Translation of a Self-questionnaire Looking for a History of Pre-eclampsia of More Than 5 Years in Women Who Have Already Had a Pregnancy of More Than 6 Months With Childbirth at Brest University Hospital.
Actual Study Start Date :
Sep 18, 2020
Anticipated Primary Completion Date :
Sep 18, 2021
Anticipated Study Completion Date :
Sep 18, 2021

Arms and Interventions

Arm Intervention/Treatment
cases

Women with a history of pre-eclampsia

Other: administration of a self-questionnaire
Women will have to fill in an online self questionnaire on pre-eclampsia

controls

Women with no history of hypertensive disorder during pregnancy

Other: administration of a self-questionnaire
Women will have to fill in an online self questionnaire on pre-eclampsia

Outcome Measures

Primary Outcome Measures

  1. Evaluate diagnostic sensitivity and specificity of the self questionnaire [Inclusion ( Day 0)]

    Presence or not of a history pre-eclampsia according to responses to the questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women who gave birth after a pregnancy of more than 6 months at Brest University Hospital between January 2002 and December 2014

  • For the cases: with a pre-eclampsia diagnosis during pregnancy

  • For the controls: with no history of hypertensive disorder during pregnancy

Exclusion Criteria:
  • Women Under legal protection

  • Women unable to read French

  • Medical interruption of pregnancy

  • Pregnancy with a delivery before 6 months

  • Women who refused to participate in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHRU de Brest Brest France 29609

Sponsors and Collaborators

  • University Hospital, Brest

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT04658966
Other Study ID Numbers:
  • PRERETRO ( 29BRC20.0133)
First Posted:
Dec 9, 2020
Last Update Posted:
Dec 9, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 9, 2020